China Life Sciences Insights

Why Ropes & Gray

Chambers Asia-Pacific 2020

Ropes & Gray’s internationally recognized China life sciences practice offers integrated and comprehensive counsel to leading investment funds and global pharmaceutical, medical device and biotechnology companies on doing business in one of the world’s fastest growing and most challenging markets.

To better serve our clients on their cutting-edge issues in this marketplace, Ropes & Gray has provided a unique resource – an exceptional and seamless cross-practice team with market-leading corporate/M&A, intellectual property, regulatory and compliance practitioners, all of whom are based on the ground in China.

Our full service offering covers all practice areas of relevance to the China life sciences industry including:

  • Mergers & Acquisitions
  • Private Equity and Venture Capital Investments
  • Complex licensing and collaborations
  • IP Counseling and Disputes
  • Regulatory Matters
  • Foreign Corrupt Practices Act (FCPA)
  • Fund Formation 

China Life Sciences Insights

Resources & Tools

China Life Sciences Overview

China Life Sciences Regulatory

China Compliance

China Intellectual Property Overview

Sign up mailing list

Contact the China Life Sciences team for additional information on our capabilities.

News & Alerts

Ropes & Gray regularly examines trends, developments and issues in the China life sciences industry to provide guidance on the rapidly changing legal landscape.

View more newsalerts, and rankings & awards


We regularly offer webinars, teleconferences and roundtable events to address recent industry trends faced by life sciences companies and investors in China.

For a full list of events click here
Cookie Settings